Opinion: Market share isn’t the only metric for biosimilars’ success
Market share is often held up as the most relevant metric for the success of a biosimilar class. I believe there are other metrics, like cost savings or signs of …
Read MoreTag: Pharma
House Democrat presses bill to encourage more diversity in clinical trials run by NIH
Rep. Robin Kelly admits that the word “diversity” has scared some of her Republican colleagues away from her effort to improve representation in clinical trials. “It’s been a little tough …
Read More
Opinion: Five years after Kymriah: Ensuring the next cell and gene therapies reach patients
Five years ago today, the Food and Drug Administration issued a landmark approval for Kymriah, the first gene therapy available in the United States. Cell and gene therapy products can …
Read More
‘Window dressing’: Eli Lilly’s after-the-fact statement on Indiana’s abortion law sends a disingenuous message
Talk about a delayed reaction. For weeks, a coterie of consumers and businesses tried to convince Indiana lawmakers not to proceed with a bill that would make the state the …
Read More
Drugmaker Teva latest to settle opioid lawsuits nationally
Drugmaker Teva announced Tuesday that it has agreed to contribute more than $4.3 billion in cash and medications to settle lawsuits in the state and local governments and Native American …
Read More
Opinion: Drug price controls are a dance with the devil: short-term savings will be overwhelmed by loss of innovation
Democrats have sent the legislative text of a sweeping proposal for drug price controls to the U.S. Senate parliamentarian, who may report on Monday whether the provisions qualify for the …
Read More
Biotech employees cash in health care’s largest salaries, while people working at providers sit near the bottom
It pays to be in the lab. It pays way less to be at the patient’s bedside. People who work at biotechs, life sciences firms, and pharmaceutical companies pull in …
Read More
Popular drug may have new benefit in men with diabetes, but not women, study shows
A new study finds that a popular erectile dysfunction drug, which is increasingly being used to try to prevent heart complications in people with type 2 diabetes, doesn’t benefit women …
Read More
Opinion: Waiving intellectual property rights is a flawed solution to achieving Covid-19 vaccine equity
When the history of the Covid-19 pandemic is written, readers will be as stunned by the flagrant collective flaw in not getting vaccines to all those who needed them as …
Read More